Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Summarize the 2023 performance of World Ex Us dividend ETFs, highlighting key drivers, top contributors, and implications for investors.
22,394 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Oklo’s latest move—acquiring Atomic Alchemy—signals more than a strategic expansion. This article breaks down what it...
A bold shift in AI strategy rewrite the investment thesis around Alphabet. OpenAI exits the AI video space, creating ...
A clear, investor-focused read on what The Trade Desk's Q1 2026 results mean for 2026. Discover growth drivers, margi...
Palantir Technologies presents a paradox: strong fundamentals on one hand, a volatile stock on the other. This articl...
Three Reddit-favored speculative bets face pivotal catalysts as spring gains fade. Archer Aviation, Rigetti Computing...
A deep dive into AVX Q1 2026 results, revenue streams, and the implications for avax (avx) 2026 earnings. Learn what ...
Eli Lilly kicked off 2026 with blockbuster sales and higher guidance, reigniting talk of a path to $1800 for Lilly st...
This week brought a sharp move in Poet Technologies shares as a dilutive financing announcement rattled investors. Le...
A wave of momentum is lifting unusual machines stock having shares higher as investors chase drone tech bets and pote...
When a stock pulls back from its highs, investors want to know if the drop is a buying signal or a warning. This guid...
A charged Tampa show reveals how public moments can ripple into personal finance choices. Learn practical budgeting t...